Opportunity Information: Apply for PA 18 323

The National Institutes of Health (NIH) funding opportunity titled "Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)" (Funding Opportunity Number: PA 18 323; CFDA: 93.213) supports investigator-initiated research projects that deepen the basic, foundational science behind a wide range of mind and body interventions. It uses the R01 mechanism, meaning it is intended for substantial, hypothesis-driven research programs that can generate broadly useful scientific knowledge about how these approaches work, for whom they work, and through what biological, psychological, or behavioral pathways they produce effects. Clinical trials are allowed but not required, so applicants may propose mechanistic laboratory studies, human experimental studies, translational work, or clinical research designs, as long as the central aim is fundamental science rather than simply testing whether an intervention works.

The scope is intentionally broad across what many people consider "integrative" or "complementary" approaches, but the emphasis is on understanding mechanisms and foundational principles. Examples specifically highlighted include mind/brain-focused practices such as meditation and hypnosis; body-based approaches such as acupuncture, massage, and spinal manipulation or mobilization; meditative movement or exercise practices such as yoga, tai chi, and qi gong; and creative modalities such as art therapy and music therapy. The FOA also welcomes integrative approaches that combine multiple components, which could include multicomponent programs that blend movement, breathwork, attention training, and behavioral skills. A key boundary is that studies focused exclusively on pharmacologic approaches are not within scope, so proposals centered only on drugs or other purely pharmacological interventions would not fit the intent of this announcement.

Because the FOA is framed around "fundamental science," projects are expected to move beyond general outcomes and focus on the underlying processes that connect a mind and body approach to changes in health or function. In practice, that could include work clarifying neurobiological, psychophysiological, immune, endocrine, autonomic, or behavioral mechanisms; identifying measurable biomarkers or intermediate phenotypes; mapping dose, intensity, or component contributions within complex interventions; studying the role of expectation, context, learning, and self-regulation; and examining individual differences that may influence response. The announcement is therefore aligned with studies that explain how and why these approaches may influence mind-body systems, rather than simply establishing efficacy in a single population without mechanistic insight.

Eligibility is expansive and includes many public, private, nonprofit, and for-profit entities. Eligible applicants listed include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations other than small businesses; small businesses; and additional categories under "others." The FOA also explicitly notes additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and non-U.S. entities (foreign organizations). This broad eligibility signals NIH interest in drawing strong applications from diverse research environments, including community and culturally grounded settings, and from institutions serving historically underrepresented groups.

Administratively, the opportunity is categorized as discretionary funding and uses a grant funding instrument under the health activity category. The announcement record indicates an original closing date of 2021-05-07 and a creation date of 2017-10-13. Award ceiling and expected award counts are not specified in the provided source data, which is common in some NIH FOA summaries because budgets and the number of awards can vary based on annual appropriations, program priorities, and the merit of submitted applications.

Overall, this FOA is best understood as an NIH invitation for rigorous, mechanism-oriented research that advances scientific understanding of mind and body interventions across a wide range of modalities, including single-method and integrative approaches, with flexibility to include clinical trials when they are the right tool for answering fundamental questions about mechanisms, components, dosing, and pathways.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
  • This funding opportunity was created on 2017-10-13.
  • Applicants must submit their applications by 2021-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 18 323

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01 Clinical Trial Optional)

Previous opportunity: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 18 323

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 18 323) also looked into and applied for these:

Funding Opportunity
Announcement of Anticipated Availability of Funds for Support for Expectant and Parenting Teens, Women, Fathers, and Their Families Apply for AH SP1 18 001

Funding Number: AH SP1 18 001
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $1,000,000
NHLBI Program Project Applications (P01 - Clinical Trials Optional) Apply for PAR 18 405

Funding Number: PAR 18 405
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) Apply for RFA AI 17 034

Funding Number: RFA AI 17 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 329

Funding Number: PAR 18 329
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 326

Funding Number: PAR 18 326
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Immunity in the Elderly (R01) Clinical Trial Optional Apply for RFA AI 17 037

Funding Number: RFA AI 17 037
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) Apply for RFA AG 18 019

Funding Number: RFA AG 18 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 18 406

Funding Number: PAR 18 406
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 020

Funding Number: RFA AG 18 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required Apply for PAR 18 407

Funding Number: PAR 18 407
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 18 410

Funding Number: PAR 18 410
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed Apply for PA 18 408

Funding Number: PA 18 408
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed Apply for PA 18 409

Funding Number: PA 18 409
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) - (Clinical Trials Not Allowed) Apply for RFA HL 18 026

Funding Number: RFA HL 18 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Program Achievements to Control the Epidemic (APACE) in South Africa Apply for 72067418RFA00001

Funding Number: 72067418RFA00001
Agency: South Africa USAID-Pretoria
Category: Health
Funding Amount: $600,000,000
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional) Apply for PAR 18 029

Funding Number: PAR 18 029
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional) Apply for PAR 18 205

Funding Number: PAR 18 205
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) Apply for PAR 18 028

Funding Number: PAR 18 028
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 18 030

Funding Number: PAR 18 030
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed) Apply for PAR 18 335

Funding Number: PAR 18 335
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 323", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: